157 related articles for article (PubMed ID: 22247229)
21. Perforin, Granzyme B, and fas ligand for molecular diagnosis of acute renal-allograft rejection: analyses on serial biopsies suggest methodological issues.
Graziotto R; Del Prete D; Rigotti P; Anglani F; Baldan N; Furian L; Valente M; Antonello A; Marchini F; D'Angelo A; Gambaro G
Transplantation; 2006 Apr; 81(8):1125-32. PubMed ID: 16641597
[TBL] [Abstract][Full Text] [Related]
22. Different regulatory and cytotoxic CD4+ T lymphocyte profiles in renal transplants with antibody-mediated chronic rejection or long-term good graft function.
Giaretta F; Bussolino S; Beltramo S; Fop F; Rossetti M; Messina M; Cantaluppi V; Ranghino A; Basso E; Camussi G; Segoloni GP; Biancone L
Transpl Immunol; 2013 Jan; 28(1):48-56. PubMed ID: 23178518
[TBL] [Abstract][Full Text] [Related]
23. Is monitoring of FOXP3 Treg cells in renal transplants during acute cellular rejection episodes useful?
Batsford S; Dickenmann M; Dürmüller U; Hopfer H; Gudat F; Mihatsch M
Clin Nephrol; 2011 Feb; 75(2):101-6. PubMed ID: 21255538
[TBL] [Abstract][Full Text] [Related]
24. Preferential accumulation of T helper cells but not cytotoxic T cells characterizes benign subclinical rejection of human liver allografts.
Baumann AK; Schlue J; Noyan F; Hardtke-Wolenski M; Lehner F; Barg-Hock H; Klempnauer J; Manns MP; Taubert R; Jaeckel E
Liver Transpl; 2016 Jul; 22(7):943-55. PubMed ID: 26929119
[TBL] [Abstract][Full Text] [Related]
25. Expression of the chemokine receptor CXCR3 in human renal allografts--a prospective study.
Hoffmann U; Segerer S; Rümmele P; Krüger B; Pietrzyk M; Hofstädter F; Banas B; Krämer BK
Nephrol Dial Transplant; 2006 May; 21(5):1373-81. PubMed ID: 16421159
[TBL] [Abstract][Full Text] [Related]
26. Impact of CMV infection on acute rejection and long-term renal allograft function: a systematic analysis in patients with protocol biopsies and indicated biopsies.
Erdbruegger U; Scheffner I; Mengel M; Schwarz A; Verhagen W; Haller H; Gwinner W
Nephrol Dial Transplant; 2012 Jan; 27(1):435-43. PubMed ID: 21712490
[TBL] [Abstract][Full Text] [Related]
27. Renal graft survival in children with early acute rejection.
Muñoz R; Romero B; Medeiros M; Zaragoza L
Pediatr Transplant; 1998 Nov; 2(4):294-8. PubMed ID: 10084732
[TBL] [Abstract][Full Text] [Related]
28. Foxp3+ T cells in peripheral blood of renal transplant recipients and clinical correlations.
Lin WX; Christiansen D; Fu LL; Roberts MA; Sandrin MS; Ierino FL
Nephrology (Carlton); 2012 May; 17(4):415-22. PubMed ID: 22308996
[TBL] [Abstract][Full Text] [Related]
29. In situ expression of mononuclear cell markers and interleukin-2 receptor in renal allograft biopsies of acute rejection and borderline cases.
Rodrigues FM; de Carvalho MF; Franchi MR; Gandin CM; Viero RM
Ren Fail; 2007; 29(1):29-35. PubMed ID: 17365907
[TBL] [Abstract][Full Text] [Related]
30. Clinical significance of protocol biopsy at one month posttransplantation in deceased-donor renal transplantation.
Mao Y; Chen J; Shou Z; Wu J; Wang H; He Q
Transpl Immunol; 2007 Apr; 17(3):211-4. PubMed ID: 17331849
[TBL] [Abstract][Full Text] [Related]
31. Sirolimus-based triple immunosupression with antithymocyte globulin induction in expanded criteria donor kidney transplantation.
Uslu A; Nart A; Taşli FA; Postaci H; Aykas A; Doğan M; Sahin T
Nephrology (Carlton); 2008 Feb; 13(1):80-6. PubMed ID: 18199109
[TBL] [Abstract][Full Text] [Related]
32. The intragraft gene activation of markers reflecting T-cell-activation and -cytotoxicity analyzed by quantitative RT-PCR in renal transplantation.
Strehlau J; Pavlakis M; Lipman M; Maslinski W; Shapiro M; Strom TB
Clin Nephrol; 1996 Jul; 46(1):30-3. PubMed ID: 8832147
[TBL] [Abstract][Full Text] [Related]
33. Characteristics of patients with Banff borderline changes in renal allograft biopsies.
El-Agroudy AE; Wafa EW; Abbas TM; El-Husseini A; Gheith OA; El-Baz M; Ghoneim MA
Exp Clin Transplant; 2009 Dec; 7(4):228-32. PubMed ID: 20353372
[TBL] [Abstract][Full Text] [Related]
34. Can histopathological findings in early renal allograft biopsies identify patients at risk for chronic vascular rejection?
Dimény E; Wahlberg J; Larsson E; Fellström B
Clin Transplant; 1995 Apr; 9(2):79-84. PubMed ID: 7599406
[TBL] [Abstract][Full Text] [Related]
35. Serial peripheral blood cytotoxic lymphocyte gene expression measurements for prediction of pancreas transplant rejection.
Cashion AK; Sabek OM; Driscoll CJ; Gaber LW; Gaber AO
Transplant Proc; 2006 Dec; 38(10):3676-7. PubMed ID: 17175364
[TBL] [Abstract][Full Text] [Related]
36. Immunophenotyping of interstitial infiltrate does not distinguish between BK virus nephropathy and acute cellular rejection.
Rogers NM; Russ GR; Cooper J; Coates PT
Nephrology (Carlton); 2009 Feb; 14(1):118-22. PubMed ID: 19143944
[TBL] [Abstract][Full Text] [Related]
37. Reduction of Foxp3-expressing regulatory T cell infiltrates during the progression of renal allograft rejection in a mouse model.
Wang S; Jiang J; Guan Q; Lan Z; Wang H; Nguan CY; Jevnikar AM; Du C
Transpl Immunol; 2008 May; 19(2):93-102. PubMed ID: 18503884
[TBL] [Abstract][Full Text] [Related]
38. Expression of granzyme A and B proteins by cytotoxic lymphocytes involved in acute renal allograft rejection.
Kummer JA; Wever PC; Kamp AM; ten Berge IJ; Hack CE; Weening JJ
Kidney Int; 1995 Jan; 47(1):70-7. PubMed ID: 7731173
[TBL] [Abstract][Full Text] [Related]
39. Comprehensive immunohistological analysis of the endothelin system in human kidney grafts.
Frank K; Zeier M; Gross ML; Waldherr R; Ritz E; Amann K
Nephrol Dial Transplant; 2006 May; 21(5):1365-72. PubMed ID: 16449275
[TBL] [Abstract][Full Text] [Related]
40. The role of C4d immunostaining in the evaluation of the causes of renal allograft dysfunction.
Ranjan P; Nada R; Jha V; Sakhuja V; Joshi K
Nephrol Dial Transplant; 2008 May; 23(5):1735-41. PubMed ID: 18065805
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
